Device Trial Radar · NCT06944639
Comparative Study of Three Collagen Membranes: 1 Non-cross-linked and 2 Cross-linked
Last checked: Nov 20, 2026Latest source record: Aug 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
25
Actual
Start
Apr 28, 2025
Primary completion
Jun 25, 2026
Study completion Jun 25, 2026
Sponsor
- Lead sponsor
- Andrea RavidaAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Dentsply Sirona Inc.
- First posted
- Apr 25, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study is being done to compare how quickly three different types of collagen membranes break down when they are exposed to the mouth. These membranes are often used in dental and oral surgery to help with healing and tissue growth. The goal is to find out if one membrane lasts longer than the others, which may help doctors choose the best option for different procedures. In this study, the membranes will be placed in the mouth in a specific area near the gums of the upper back teeth. The study is designed so that neither the patients nor the researchers evaluating the results will know which membrane is which (this is called a double-blind study). Over time, researchers will measure how much each membrane has broken down. This information may help improve treatment planning and patient outcomes in dental care.
Conditions
- Bone Regeneration
Interventions
Membrane Jason MB GmbH Non-cross-linked (NCL)Device
The membrane will be stabilized in the oral mucosa using sutures and flowable composite.
Membrane BioMend Extend Glutaraldehyde cross-linkedDevice
The membrane will be stabilized in the oral mucosa using sutures and flowable composite.
Membrane OSSIX Agile Ribose cross-linked (RCL)Device
The membrane will be stabilized in the oral mucosa using sutures and flowable composite.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Degradation rates of three different collagen membranes simulating exposure to the oral environment.Time frame: 10 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of Pittsburgh, School of Dental Medicine
Pittsburgh, Pennsylvania
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.